Lifeward receives prior authorization from UnitedHealthcare for ReWalk 7

Lifeward (LFWD) announced that it received its first prior authorization from a UnitedHealthcare (UNH) Medicare Advantage Plan for a ReWalk 7 Personal Exoskeleton. “This prior authorization approval from a UnitedHealthcare Medicare Advantage Plan signals a significant advancement in payer adoption of the ReWalk Exoskeleton,” said Mark Grant, CEO of Lifeward. “As coverage expands and prior authorizations accelerate, we’re seeing greater predictability in reimbursement, improved cash flow dynamics, and a clearer pathway toward scalable, sustainable growth in the U.S. market.”